Therma Bright (TSE:THRM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Therma Bright Inc., a medical device technology developer, has added Michael Raimondo, an expert with 30 years of experience in the medical and pharmaceutical industry, to its advisory board to boost sales and business development, particularly for its Venowave device. Raimondo’s proven track record in sales negotiations and business growth is expected to significantly contribute to Therma Bright’s expansion efforts across the U.S. healthcare market.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.